United States Drug Development

• U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Forecast to 2028

  Feb 09, 2022  |  Published by: Meticulous Market Research  |  USD 4,175

  ... grow at a CAGR of 13.0% from 2021 to 2028 to reach $2.01 billion by 2028 Following a thorough secondary and primary research and in-depth analysis of the market scenario, the report carries out the ... Read More

< prev 1 2 next >